Provided by Tiger Trade Technology Pte. Ltd.

Amgen

429.88
-2.5400-0.59%
Post-market: 433.003.12+0.73%18:36 EDT
Volume:2.34M
Turnover:1.01B
Market Cap:231.48B
PE:26.70
High:431.85
Open:428.59
Low:426.00
Close:432.42
52wk High:447.03
52wk Low:269.77
Shares:538.48M
Float Shares:536.99M
Volume Ratio:1.13
T/O Rate:0.44%
Dividend:9.80
Dividend Rate:2.28%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:19.81
PE(LYR):30.21

Loading ...

Amgen price target raised to $440 from $420 at UBS

TIPRANKS
·
Aug 05

Amgen Shares up 5% After Q2 Results Beat Estimates; FY Profit Forecast Raise

THOMSON REUTERS
·
Aug 05

Dow's 500-Point Rally Led by Gains in Amgen, Nvidia Corp. Shares

Dow Jones
·
Aug 05

Movement Alert|Amgen Rises 4.2% in Regular Trading, Q2 Earnings Significantly Beat Expectations with Raised Full-Year Guidance

Market Focus
·
Aug 05

Amgen Inc : Canaccord Genuity Raises Target Price to $384 from $366

THOMSON REUTERS
·
Aug 05

Immuneering Expects Cash Runway to Fund Operations into 2029

Reuters
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Exagen (XGN), Amgen (AMGN) and Arvinas Holding Company (ARVN)

TIPRANKS
·
Aug 05

Morgan Stanley Adjusts Price Target on Amgen to $351 From $333, Maintains Equalweight Rating

MT Newswires Live
·
Aug 05

Amgen Inc : Scotiabank Raises Target Price to $450 from $385

THOMSON REUTERS
·
Aug 05

Sino Biopharmaceutical Stock Slips 1.2% in Hong Kong

Dow Jones
·
Aug 05

Street View: Amgen Builds Momentum with Blockbusters, Biosimilars and a Pipeline in Waiting

Reuters
·
Aug 05

U.S. Research Roundup-Ametek, Ball Corp, McDonald's

Reuters
·
Aug 05

Amgen Inc : Morgan Stanley Raises Target Price to $351 from $333

THOMSON REUTERS
·
Aug 05

Amgen Inc : Oppenheimer Raises Target Price to $450 from $400

THOMSON REUTERS
·
Aug 05

TD Cowen Sticks to Its Buy Rating for Amgen (AMGN)

TIPRANKS
·
Aug 05

Dow Jones Top Company Headlines at 7 PM ET: SpaceX Revenue Could Reach $1 Trillion, Elon Musk Says | Paramount's ...

Dow Jones
·
Aug 05

Amgen Announces Availability of Q2 2026 Earnings Report Release

Reuters
·
Aug 05

Amgen's Strong Second Quarter Drug Sales Drive Upward Forecast Revision and Early-Stage Weight Loss Drug Termination

Deep News
·
Aug 05

Amgen Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Amgen Exec Says Continues to Expect Capital Expenditures of About $2.6 Billion in 2026 to Scale Manufacturing Capacity, Including for Maritide's Launch

THOMSON REUTERS
·
Aug 05